Dyrskjot L - Search Results

1

Selection of microsatellite markers for bladder cancer diagnosis without the need for corresponding blood.

van Tilborg AA, Kompier LC, Lurkin I, Poort R, El Bouazzaoui S, van der Keur K, Zuiverloon T, Dyrskjot L, Orntoft TF, Roobol MJ, Zwarthoff EC. van Tilborg AA, et al. Among authors: dyrskjot l. PLoS One. 2012;7(8):e43345. doi: 10.1371/journal.pone.0043345. Epub 2012 Aug 22. PLoS One. 2012. PMID: 22927958 Free PMC article.

2

Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer.

Christensen E, Nordentoft I, Birkenkamp-Demtröder K, Elbæk SK, Lindskrog SV, Taber A, Andreasen TG, Strandgaard T, Knudsen M, Lamy P, Agerbæk M, Jensen JB, Dyrskjøt L. Christensen E, et al. Among authors: dyrskjot l. Clin Cancer Res. 2023 Apr 14;29(8):1582-1591. doi: 10.1158/1078-0432.CCR-22-3250. Clin Cancer Res. 2023. PMID: 36780195 Free PMC article.

3

NGS-Based Tumor-Informed Analysis of Circulating Tumor DNA.

Nordentoft I, Birkenkamp-Demtröder K, Dyrskjøt L. Nordentoft I, et al. Among authors: dyrskjot l. Methods Mol Biol. 2023;2684:179-197. doi: 10.1007/978-1-0716-3291-8_11. Methods Mol Biol. 2023. PMID: 37410235

4

Identifying distinct classes of bladder carcinoma using microarrays.

Dyrskjøt L, Thykjaer T, Kruhøffer M, Jensen JL, Marcussen N, Hamilton-Dutoit S, Wolf H, Orntoft TF. Dyrskjøt L, et al. Nat Genet. 2003 Jan;33(1):90-6. doi: 10.1038/ng1061. Epub 2002 Dec 9. Nat Genet. 2003. PMID: 12469123

5

Technical evaluation of cDNA microarrays.

Frederiksen CM, Aaboe M, Dyrskjøt L, Laurberg S, Wolf H, Ørntoft TF, Kruhøffer M. Frederiksen CM, et al. Among authors: dyrskjot l. APMIS Suppl. 2003;(109):96-101. APMIS Suppl. 2003. PMID: 12874958

6

Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification.

Dyrskjøt L, Kruhøffer M, Thykjaer T, Marcussen N, Jensen JL, Møller K, Ørntoft TF. Dyrskjøt L, et al. Cancer Res. 2004 Jun 1;64(11):4040-8. doi: 10.1158/0008-5472.CAN-03-3620. Cancer Res. 2004. PMID: 15173019

7

A molecular signature in superficial bladder carcinoma predicts clinical outcome.

Dyrskjøt L, Zieger K, Kruhøffer M, Thykjaer T, Jensen JL, Primdahl H, Aziz N, Marcussen N, Møller K, Orntoft TF. Dyrskjøt L, et al. Clin Cancer Res. 2005 Jun 1;11(11):4029-36. doi: 10.1158/1078-0432.CCR-04-2095. Clin Cancer Res. 2005. PMID: 15930337

8

Gene expression profiling of noninvasive primary urothelial tumours using microarrays.

Aaboe M, Marcussen N, Jensen KM, Thykjaer T, Dyrskjøt L, Orntoft TF. Aaboe M, et al. Among authors: dyrskjot l. Br J Cancer. 2005 Nov 14;93(10):1182-90. doi: 10.1038/sj.bjc.6602813. Br J Cancer. 2005. PMID: 16265353 Free PMC article.

9

Role of activating fibroblast growth factor receptor 3 mutations in the development of bladder tumors.

Zieger K, Dyrskjøt L, Wiuf C, Jensen JL, Andersen CL, Jensen KM, Ørntoft TF. Zieger K, et al. Among authors: dyrskjot l. Clin Cancer Res. 2005 Nov 1;11(21):7709-19. doi: 10.1158/1078-0432.CCR-05-1130. Clin Cancer Res. 2005. PMID: 16278391

10

SOX4 expression in bladder carcinoma: clinical aspects and in vitro functional characterization.

Aaboe M, Birkenkamp-Demtroder K, Wiuf C, Sørensen FB, Thykjaer T, Sauter G, Jensen KM, Dyrskjøt L, Ørntoft T. Aaboe M, et al. Among authors: dyrskjot l. Cancer Res. 2006 Apr 1;66(7):3434-42. doi: 10.1158/0008-5472.CAN-05-3456. Cancer Res. 2006. PMID: 16585165 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

185 results

Search Page

Filters